Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shamir R Mehta

Showing results (91-100 of 212) with videos related to

Pageof 22
Sort By:
The Canadian Journal of Cardiology|August 28, 2013
Focused 2012 update of the Canadian Cardiovascular Society guidelines for the use of antiplatelet therapyJean-François Tanguay, Alan D Bell, Margaret L Ackman, et al.
The New England Journal of Medicine|March 16, 2006
Comparison of fondaparinux and enoxaparin in acute coronary syndromes, Salim Yusuf, Shamir R Mehta, et al.
The Canadian Journal of Cardiology|June 20, 2020
A Critical Comparison of Canadian and International Guidelines Recommendations for Antiplatelet Therapy in Coronary Artery DiseaseGuillaume Marquis-Gravel, Shamir R Mehta, Marco Valgimigli, et al.
The American Journal of Cardiology|December 9, 2022
Clinical Significance of Culprit Vessel Occlusion in Patients With Non-ST-Elevation Myocardial Infarction Who Underwent Percutaneous Coronary InterventionBatric Popovic, Gregory Ducrocq, Yedid Elbez, et al.
Circulation. Cardiovascular Interventions|June 14, 2018
Activated Clotting Time to Guide Heparin Dosing in Non-ST-Segment-Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors: Impact on Ischemic and Bleeding Outcomes: Insights From the TAO TrialJean-Guillaume Dillinger, Gregory Ducrocq, Yedid Elbez, et al.
American Heart Journal|September 24, 2017
Effects of ticagrelor versus clopidogrel on platelet function in fibrinolytic-treated STEMI patients undergoing early PCIPayam Dehghani, Andrea Lavoie, Shahar Lavi, et al.
JACC. Cardiovascular Interventions|October 22, 2021
Impact of Transcatheter Mitral Valve Repair on Preprocedural and Postprocedural Hospitalization RatesAndrew Czarnecki, Lu Han, Wael Abuzeid, et al.
The Canadian Journal of Cardiology|January 16, 2026
Clinical care for patients with elevated lipoprotein(a) in Canada: a practical framework for screening, risk assessment and managementGeorge Thanassoulis, Sonia Anand, Benoit J Arsenault, et al.
The New England Journal of Medicine|June 26, 2009
Routine early angioplasty after fibrinolysis for acute myocardial infarctionWarren J Cantor, David Fitchett, Bjug Borgundvaag, et al.
American Heart Journal|September 18, 2012
Efficacy of early invasive management post-fibrinolysis in men versus women with ST-elevation myocardial infarction: a subgroup analysis from Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI)Vineet Bhan, Warren J Cantor, Raymond T Yan, et al.
Pageof 22

Showing results (91-100 of 212) with videos related to

Sort By:
Pageof 22
The Canadian Journal of Cardiology|August 28, 2013
Focused 2012 update of the Canadian Cardiovascular Society guidelines for the use of antiplatelet therapyJean-François Tanguay, Alan D Bell, Margaret L Ackman, et al.
The New England Journal of Medicine|March 16, 2006
Comparison of fondaparinux and enoxaparin in acute coronary syndromes, Salim Yusuf, Shamir R Mehta, et al.
The Canadian Journal of Cardiology|June 20, 2020
A Critical Comparison of Canadian and International Guidelines Recommendations for Antiplatelet Therapy in Coronary Artery DiseaseGuillaume Marquis-Gravel, Shamir R Mehta, Marco Valgimigli, et al.
The American Journal of Cardiology|December 9, 2022
Clinical Significance of Culprit Vessel Occlusion in Patients With Non-ST-Elevation Myocardial Infarction Who Underwent Percutaneous Coronary InterventionBatric Popovic, Gregory Ducrocq, Yedid Elbez, et al.
Circulation. Cardiovascular Interventions|June 14, 2018
Activated Clotting Time to Guide Heparin Dosing in Non-ST-Segment-Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors: Impact on Ischemic and Bleeding Outcomes: Insights From the TAO TrialJean-Guillaume Dillinger, Gregory Ducrocq, Yedid Elbez, et al.
American Heart Journal|September 24, 2017
Effects of ticagrelor versus clopidogrel on platelet function in fibrinolytic-treated STEMI patients undergoing early PCIPayam Dehghani, Andrea Lavoie, Shahar Lavi, et al.
JACC. Cardiovascular Interventions|October 22, 2021
Impact of Transcatheter Mitral Valve Repair on Preprocedural and Postprocedural Hospitalization RatesAndrew Czarnecki, Lu Han, Wael Abuzeid, et al.
The Canadian Journal of Cardiology|January 16, 2026
Clinical care for patients with elevated lipoprotein(a) in Canada: a practical framework for screening, risk assessment and managementGeorge Thanassoulis, Sonia Anand, Benoit J Arsenault, et al.
The New England Journal of Medicine|June 26, 2009
Routine early angioplasty after fibrinolysis for acute myocardial infarctionWarren J Cantor, David Fitchett, Bjug Borgundvaag, et al.
American Heart Journal|September 18, 2012
Efficacy of early invasive management post-fibrinolysis in men versus women with ST-elevation myocardial infarction: a subgroup analysis from Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI)Vineet Bhan, Warren J Cantor, Raymond T Yan, et al.
Pageof 22